G1 Pharma (GTHX): יחס מחיר להכנסות

סמל מסחרי של g1therapeutics.com (GTHX)

The stability of the US healthcare system and the humanitarian status of oncology minimize geopolitical risks, which supports the median P/S for G1 Therapeutics, Inc. (GTHX). Meanwhile, the 6.40 level reflects the state of the parameter amid the integration of AI into CDK4/6 inhibitor design. This chart's price action also depends on the recognition of bone marrow protection methods and insurance reimbursement conditions.

GTHX מכפיל P/S G1 Therapeutics (04.07.2022 - 28.09.2024)

G1 Therapeutics Inc. (GTHX) - פילוחי מדדים ודוחות פיננסיים

- ציטוטים נוכחיים ותחזית שווי ממוצעת:
אנליטיקה מסכמת של החברה:G1 Pharma
מוצר סדרתי של G1 Therapeutics

Investors utilize multiples to filter for high-quality assets, allowing them to compare a business's market price with its actual cash flow. This price-to-sales ratio measures the premium for future growth by assessing how much the market is paying for every dollar of sales of the unique drug Cosela, which helps identify whether G1 Therapeutics, Inc. (GTHX) is overvalued or undervalued based on this chart.